|
1
|
Ghouri YA, Mian I and Blechacz B: Cancer
review: Cholangiocarcinoma. J Carcinog. 14:12015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tejeda-Maldonado J, Garcia-Juarez I,
Aguirre-Valadez J, González-Aguirre A, Vilatobá-Chapa M,
Armengol-Alonso A, Escobar-Penagos F, Torre A, Sánchez-Ávila JF and
Carrillo-Pérez DL: Diagnosis and treatment of hepatocellular
carcinoma: An update. World J Hepatol. 7:362–376. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kinoshita A, Onoda H, Fushiya N, Koike K,
Nishino H and Tajiri H: Staging systems for hepatocellular
carcinoma: Current status and future perspectives. World J Hepatol.
7:406–424. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kimhofer T, Fye H, Taylor-Robinson S,
Thursz M and Holmes E: Proteomic and metabonomic biomarkers for
hepatocellular carcinoma: A comprehensive review. Br J Cancer.
112:1141–1156. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee RC, Feinbaum RL and Ambros V: The C.
elegans heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Malumbres M and Barbacid M: RAS oncogenes:
The first 30 years. Nat Rev Cancer. 3:459–465. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nicolaidou V and Koufaris C: MicroRNA
responses to environmental liver carcinogens: Biological and
clinical significance. Clin Chim Acta. 445:25–33. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hung CH, Chiu YC, Chen CH and Hu TH:
MicroRNAs in hepatocellular carcinoma: Carcinogenesis, progression
and therapeutic target. Biomed Res Int. 2014:4864072014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Paraskevopoulou MD, Georgakilas G,
Kostoulas N, Reczko M, Maragkakis M, Dalamagas TM and Hatzigeorgiou
AG: DIANA-LncBase: Experimentally verified and computationally
predicted microRNA targets on long non-coding RNAs. Nucleic Acids
Res. 41:D239–D245. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
John B, Enright AJ, Aravin A, Tuschl T,
Sander C and Marks DS: Human MicroRNA targets. PLoS Biol.
2:e3632004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Irizarry RA, Hobbs B, Collin F,
Beazer-Barclay YD, Antonellis KJ, Scherf U and Speed TP:
Exploration, normalization and summaries of high density
oligonucleotide array probe level data. Biostatistics. 4:249–264.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vergoulis T, Vlachos IS, Alexiou P,
Georgakilas G, Maragkakis M, Reczko M, Gerangelos S, Koziris N,
Dalamagas T and Hatzigeorgiou AG: TarBase 6.0: Capturing the
exponential growth of miRNA targets with experimental support.
Nucleic Acids Res. 40:D222–D229. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gordon CA, Gulzar ZG and Brooks JD: NUSAP1
expression is upregulated by loss of RB1 in prostate cancer cells.
Prostate. 75:517–526. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sabir M, Baig RM, Ali K, Mahjabeen I,
Saeed M and Kayani MA: Retinoblastoma (RB1) pocket domain mutations
and promoter hyper-methylation in head and neck cancer. Cell Oncol
(Dordr). 37:203–213. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kansara M and Thomas DM: RB1-mediated
cell-autonomous and host-dependent oncosuppressor mechanisms in
radiation-induced osteosarcoma. Oncoimmunology. 3:e275692014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Anwar SL, Krech T, Hasemeier B, Schipper
E, Schweitzer N, Vogel A, Kreipe H and Lehmann U: Deregulation of
RB1 expression by loss of imprinting in human hepatocellular
carcinoma. J Pathol. 233:392–401. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen P, Wang BL, Pan BS and Guo W:
MiR-1297 regulates the growth, migration and invasion of colorectal
cancer cells by targeting cyclo-oxygenase-2. Asian Pac J Cancer
Prev. 15:9185–9190. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang C, Chi YL, Wang PY, Wang YQ, Zhang
YX, Deng J, Lv CJ and Xie SY: miR-511 and miR-1297 inhibit human
lung adenocarcinoma cell proliferation by targeting oncogene TRIB2.
PloS one. 7:e460902012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li X, Wang HL, Peng X, Zhou HF and Wang X:
miR-1297 mediates PTEN expression and contributes to cell
progression in LSCC. Biochem Biophys Res Commun. 427:254–260. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Di Fiore R, D'Anneo A, Tesoriere G and
Vento R: RB1 in cancer: Different mechanisms of RB1 inactivation
and alterations of pRb pathway in tumorigenesis. J Cell Physiol.
228:1676–1687. 2013. View Article : Google Scholar : PubMed/NCBI
|
